Evidence of pleiotropy by statins: leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors

他汀类药物多效性的证据：白细胞 Rho 激酶 (ROCK) 活性和经皮冠状动脉介入治疗前预先使用他汀类药物是临床血管结局的预测因子。